MEDPAL AI is trading 16.73% up now at £6.07 after the company published an August Trading Update on September 7, 2026. - The company's annualised revenue run rate surged to approximately £28 million by August 2026, driven entirely by organic trading across NHS dispensing, care homes, and private weight management. - Its New Health GLP-1 weight-loss clinic generated £1.83 million in August revenue, an 809 per cent month-on-month leap from July. - The September 4 share issuance announcement related to the eMARx acquisition creates modest dilution but does not explain the upward price movement.